HighMark Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $594 | Hold |
155
| – | – | ﹤0.01% | 550 |
|
2025
Q1 | $891 | Hold |
155
| – | – | ﹤0.01% | 496 |
|
2024
Q4 | $773 | Hold |
155
| – | – | ﹤0.01% | 506 |
|
2024
Q3 | $835 | Hold |
155
| – | – | ﹤0.01% | 524 |
|
2024
Q2 | $513 | Hold |
155
| – | – | ﹤0.01% | 535 |
|
2024
Q1 | $507 | Hold |
155
| – | – | ﹤0.01% | 525 |
|
2023
Q4 | $544 | Hold |
155
| – | – | ﹤0.01% | 533 |
|
2023
Q3 | $1.04K | Hold |
155
| – | – | ﹤0.01% | 503 |
|
2023
Q2 | $1.3K | Hold |
155
| – | – | ﹤0.01% | 489 |
|
2023
Q1 | $1.54K | Hold |
155
| – | – | ﹤0.01% | 522 |
|
2022
Q4 | $1.08K | Hold |
155
| – | – | ﹤0.01% | 468 |
|
2022
Q3 | $1K | Sell |
155
-610
| -80% | -$3.94K | ﹤0.01% | 455 |
|
2022
Q2 | $3K | Sell |
765
-2,000
| -72% | -$7.84K | ﹤0.01% | 388 |
|
2022
Q1 | $12K | Sell |
2,765
-350
| -11% | -$1.52K | 0.01% | 233 |
|
2021
Q4 | $12K | Sell |
3,115
-1,442
| -32% | -$5.56K | 0.01% | 230 |
|
2021
Q3 | $40K | Buy |
4,557
+197
| +5% | +$1.73K | 0.03% | 129 |
|
2021
Q2 | $49K | Buy |
4,360
+3,501
| +408% | +$39.3K | 0.04% | 115 |
|
2021
Q1 | $10K | Buy |
+859
| New | +$10K | 0.01% | 229 |
|